VOGLIMAC GM TABLET 1mg/500mg/0.3mg

VOGLIMAC GM TABLET 1mg/500mg/0.3mg is utilized in the treatment of type 2 diabetes.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. VOGLIMAC GM TABLET 1mg/500mg/0.3mg is to be taken with food.VOGLIMAC GM TABLET 1mg/500mg/0.3mg may cause stomach upset if taken on empty stomach.

Hypoglycemia (low blood sugar level), Nausea, Diarrhoea, Altered taste, Flatulence, Stomach pain, Headache, Skin rash, Respiratory tract infection.

VOGLIMAC GM TABLET 1mg/500mg/0.3mg is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.

Increased thirst, Frequent urination, Increased hunger, Unintended weight loss, Fatigue, Blurred vision, Slow-healing sores, Frequent infections, Numbness or tingling in the hands or feet, Areas of darkened skin, usually in the armpits and neck.